Analysis of the epidemiological situation on COVID-19: third and fourth waves
https://doi.org/10.25789/YMJ.2021.76.17
Abstract
The dynamic analysis of prevalence, morbidity, mortality rate and case fatality rate from COVID-19 for the period from April 1, 2021 to September 30, 2021 was carried out. The highest prevalence of COVID-19 is registered in the USA, the UK, France. China has consistently low levels of prevalence and morbidity of new coronavirus infection. Increase in the proportion of fully vaccinated persons reduces morbidity of COVID-19.
About the Authors
T. E. PopovaRussian Federation
Popova Tatyana E – Grand PhD in Medical Sciences, deputy Director for Science
Yakutsk
O. G. Tikhonova
Russian Federation
Tikhonova Olga G – Scientific Secretary
Yakutsk
A. N. Romanova
Russian Federation
Romanova Anna N – Grand PhD in Medical Sciences, Director for Science
Yakutsk
A. A. Tappakhov
Russian Federation
Tappakhov Alexey A – Candidate of Sciences in Medicine, Associate Professor at the Department of Neurology and Psychiatry of the Medical Institute; Head Researcher of the Laboratory of Neuropsychophysiological Researches; Senior Researcher, Center for Neurodegenerative Diseases
Yakutsk
M. E. Andreev
Russian Federation
Andreev Michil E – doctor of functional diagnostics at the Clinic
Yakutsk
E. E. Konnikova
Russian Federation
Konnikova Edilia Eduardovna – Candidate of Medical Sciences, Associate Professor, Medical Institute
References
1. Popova TE, Tikhonova OG, Romanova AN, et al. Analysis of the epidemiological situation for COVID-19. Yakut Medical Journal. 2020; 3 (71): 63-37. DOI 10.25789/YMJ.2020.71.17
2. Popova TE, Tikhonova OG, Romanova AN, et al. Analysis of the epidemiological situation for COVID-19: second wave. Yakut Medical Journal. 2021; 1 (72): 61-64. DOI 10.25789/YMJ.2021.73.17
3. Temporary guidelines of the Ministry of Health of the Russian Federation. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 13.1 (17.11.2021).
4. Pshenichnaya NYu, Veselova EI, Semenova DA, et al. COVID-19 - a new global threat to humanity. Epidemiologia i infeksionnye bolezni: aktual’nye voprosy. 2020; 1: 6-13. https://dx.doi.org/10.18565/epidem.2020.10.1.6-13
5. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). Aleem A, Akbar Samad AB, Slenker AK.2021 Jul 18. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–.PMID: 34033342 https://www.gisaid.org/hcov19-variants/Our World in Data Coronavirus (COVID-19) Vaccinations. [(accessed on 1 March 2021)];University of Oxford. 2021
6. The Implementation of Mass-Vaccination against SARS-CoV-2: A Systematic Review of Existing Strategies and Guidelines. Hasan T, Beardsley J, Marais BJ, Nguyen TA, Fox GJ. Vaccines (Basel). 2021 Apr 1;9(4):326. doi: 10.3390/vaccines9040326.
7. Torjesen I. Covid-19 will become endemic but with decreased potency over time, scientists believe. BMJ. 2021 Feb 18;372:n494. doi: 10.1136/bmj.n494
8. World Health Organisation. The COVID-19 Candidate Vaccine Landscape and Tracke. World Health Organisation; Geneva, Switzerland: 2021.
9. https://covid19.who.int/region/amro/country/us
10. https://covid19.who.int/region/euro/country/it
11. https://covid19.who.int/region/wpro/country/cn
12. https://www.gisaid.org/hcov19-variants/
13. https://index.minfin.com.ua/reference/coronavirus/
14. https://ncov.blog/countries/us/
15. https://news.mail.ru/coronavirus/stat/world/
16. https://planetcalc.ru/8657/
17. https://www.worldometers.info/coronavirus/country/italy/
18. https://zona.media/coronagraph
Review
For citations:
Popova T.E., Tikhonova O.G., Romanova A.N., Tappakhov A.A., Andreev M.E., Konnikova E.E. Analysis of the epidemiological situation on COVID-19: third and fourth waves. Yakut Medical Journal. 2021;(4):72-75. https://doi.org/10.25789/YMJ.2021.76.17